Kiefer Meghan M, Silverman Julie B, Young Bessie A, Nelson Karin M
Department of Medicine, Division of General Internal Medicine, University of Washington School of Medicine, Seattle, WA, USA,
J Gen Intern Med. 2015 May;30(5):612-8. doi: 10.1007/s11606-014-3147-8. Epub 2014 Dec 23.
There are few current population-based estimates of the patterns of diabetes screening in the United States. The American Diabetes Association (ADA) recommends universal screening of adults ≥ 45 years, and high-risk adults < 45 years, but there is no current assessment of ADA guideline performance in detecting diabetes and prediabetes. Furthermore, data on racial/ethnic patterns of screening are limited.
Our aim was to estimate diabetes screening prevalence for the US adult population and specifically for those who meet ADA criteria; to report the prevalence of prediabetes and diabetes among these groups; and to determine if high-risk race/ethnicity was associated with reported screening.
This was a Cross-sectional survey.
Non-pregnant adults (≥ 21 years) without diabetes or prediabetes who participated in the National Health and Nutrition Examination Survey (NHANES) in 2005-2012 (n = 17,572) were included in the study. "Screening-recommended" participants, classified by ADA criteria, included (1) adults ≥ 45 years and (2) "high-risk" adults < 45 years. "Screening-not-recommended" participants were adults < 45 years who did not meet criteria.
Diabetes screening status was obtained by self-report. We used calibrated HbA1c and/or fasting glucose levels to define undiagnosed diabetes and prediabetes.
Seventy-six percent of the study population (approximately 136 million US adults) met ADA criteria. Among them, less than half (46.2%) reported screening; undiagnosed diabetes affected 3.7% (5 million individuals), and undiagnosed prediabetes affected 36.3% (49 million people.) African Americans were more likely to report screening, both among adults ≥ 45 years and among "high risk" younger adults (OR 1.27 and 1.36, respectively.) Hispanic participants were also more likely to report screening (OR 1.31 for older adults, 1.42 for younger adults.) The screening rate among "screening-not-recommended" adults was 29.6%; the prevalence of diabetes and prediabetes were 0.4 and 10.2%, respectively.
In a nationally representative sample, 76% of adults met ADA screening criteria, of whom fewer than half reported screening. Limitations include cross-sectional design and screening self-report.
目前基于美国人群的糖尿病筛查模式估计数据较少。美国糖尿病协会(ADA)建议对45岁及以上的成年人以及45岁以下的高危成年人进行普遍筛查,但目前尚无对ADA指南在检测糖尿病和糖尿病前期方面表现的评估。此外,关于筛查的种族/民族模式的数据有限。
我们的目的是估计美国成年人群,特别是符合ADA标准人群的糖尿病筛查患病率;报告这些人群中糖尿病前期和糖尿病的患病率;并确定高危种族/民族与报告的筛查情况是否相关。
这是一项横断面调查。
纳入了2005 - 2012年参加美国国家健康与营养检查调查(NHANES)的无糖尿病或糖尿病前期的非妊娠成年人(≥21岁)(n = 17,572)。根据ADA标准分类的“推荐筛查”参与者包括:(1)45岁及以上的成年人;(2)45岁以下的“高危”成年人。“不推荐筛查”参与者为45岁以下不符合标准的成年人。
通过自我报告获取糖尿病筛查状态。我们使用校准的糖化血红蛋白(HbA1c)和/或空腹血糖水平来定义未诊断的糖尿病和糖尿病前期。
76%的研究人群(约1.36亿美国成年人)符合ADA标准。其中,不到一半(46.2%)报告进行了筛查;未诊断的糖尿病影响了3.7%(500万人),未诊断的糖尿病前期影响了36.3%(4900万人)。非裔美国人在45岁及以上成年人以及“高危”年轻成年人中报告进行筛查的可能性更高(分别为OR 1.27和1.36)。西班牙裔参与者报告进行筛查的可能性也更高(年龄较大的成年人OR为1.31,年龄较小的成年人OR为1.42)。“不推荐筛查”成年人中的筛查率为29.6%;糖尿病和糖尿病前期的患病率分别为0.4%和10.2%。
在一个具有全国代表性的样本中,76%的成年人符合ADA筛查标准,但其中报告进行筛查的不到一半。局限性包括横断面设计和筛查自我报告。